HeartBeam Receives FDA Clearance For ECG Software
HeartBeam has received FDA clearance for its 12-lead ECG synthesis software. This innovation positions the company as second globally in cardiac diagnostic innovation and aims to transform remote heart monitoring.
Topics
Developing
- 862d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 862d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 862d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 862d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
KIRO FM Seattle
“HeartBeam has received FDA clearance for its ECG software”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade